Wegovy Price Compared to Mounjaro: What Private Treatment Costs in the UK

You're comparing two prices, but the pens start at different points

Imagine you've just received quotes from two different clinics (one for Wegovy, one for Mounjaro) and the Mounjaro figure is noticeably higher. That's a real pattern in the UK private market right now. Eli Lilly raised Mounjaro's UK list price from 1 September 2025; at the highest dose, the list price moved from around £122 to around £330 per four-week pen. Novo Nordisk's pricing for Wegovy has remained more stable, and at entry doses Wegovy is typically the lower-cost option. At higher doses, the gap narrows considerably. For anyone titrating up to 10mg, 12.5mg or 15mg Mounjaro, the monthly cost can exceed typical Wegovy 2.4mg pricing by a meaningful margin, though both remain within broadly similar territory at mid-range doses.

The reported market range for UK private treatment sits roughly between £149 and £375 a month across doses and providers, and these figures are widely cited and hedged as approximations for good reason: pricing varies, and individual dose requirements differ. A fair comparison of Wegovy vs Mounjaro cost has to account for where in the titration schedule you actually are, not just the entry-level figure. If you want to see how Wegovy vs Mounjaro prices compare across every available dose, our breakdown walks through what each pen costs at each stage of titration. Our guide to how much Wegovy costs compared to Mounjaro walks through the figures dose by dose. The NICE appraisal of tirzepatide (TA1026) and its appraisal of semaglutide (TA875) both confirm the licensed clinical context for these medicines; pricing is a private-market matter, but eligibility and appropriate use are defined by the regulator.

What a headline price often leaves out

You've probably noticed that the figures you see advertised don't always tell the same story. Some providers charge separately for the initial consultation. Others add a prescription fee on top, or charge for each dose-review before issuing a repeat. Delivery may be quoted as free at lower doses but billed at higher ones. Aftercare (the clinical support you'd want if you experience side effects or need guidance on what to do at a dose increase) sometimes exists only as a premium add-on.

This matters particularly when you're comparing Wegovy and Mounjaro prices, because both medicines follow a titration schedule. Mounjaro starts at 2.5mg and the prescriber typically moves the dose upward every four weeks; Wegovy has its own stepped schedule. If each of those reviews carries an additional charge, the true cost over six or twelve months can look very different from the headline monthly figure, which is why a detailed Mounjaro and Wegovy price comparison that accounts for those add-up scenarios is worth working through before you commit. The point isn't to alarm (most reputable providers are transparent) but reading the small print before committing saves surprises later. That's something our frequently asked questions page covers in practical terms too.

Where nume sits on this, plainly stated

We're not going to win on price against every provider in the market. That's a deliberate choice. At nume, one transparent figure covers the consultation, the prescription, the treatment itself, the clinical re-review at each repeat, aftercare seven days a week, and free next-working-day tracked delivery. There's no subscription structure that automatically dispatches your next pen; every repeat order is individually re-reviewed by a real prescriber. Our clinical team, led by GPhC-registered Independent Prescribers, personally reviews every consultation the same day, our prescribers read your answers and make a clinical decision, not software running a checklist.

If you're choosing between Wegovy and Mounjaro on cost grounds alone, that's understandable, and we'll always answer that question honestly. If you'd also like to understand how the Mounjaro vs Ozempic price compares, that page sets out the figures across doses so you can weigh up all three options together. Our page on Mounjaro vs Wegovy price in the UK sets out how the two treatments compare across doses and providers, which can be useful context if you're weighing up more than two treatments. Treatment pricing is shown on our weight-loss treatment overview, and our team at clinical oversight level is available if you want to understand your options before starting.

Why price is the wrong starting point for a prescription medicine

There's an honest thing worth saying here: if you're spending time comparing the two lowest prices you can find online, that energy is probably better spent checking the pharmacy. Both Mounjaro and Wegovy are prescription-only medicines. The only legal route to either is through a clinical assessment leading to a prescription, issued by a real prescriber, dispensed by a registered pharmacy. The MHRA has issued repeated public warnings about counterfeit weight-loss pens sold via social media and unverified websites; in October 2025, enforcement teams raided the first illicit UK site manufacturing fake tirzepatide pens. You can verify any online pharmacy on the GPhC register in about thirty seconds. We'd encourage you to do that with us too.

A lower price from an unverified source isn't a saving, it's a different product at a lower price. The right comparison is between regulated services offering genuine medicines through a proper clinical pathway. Within that group, the better question is which service offers the most complete clinical support, not the smallest number on the pricing page. Suspected counterfeit sellers can be reported directly at the MHRA's Yellow Card scheme, that applies to anything sold without a prescription, at prices that don't add up, or through channels that can't show a pharmacy registration.